首页> 外文期刊>Oncology Research >Inhibition of Proliferation, Migration, and Invasion by Knockdown of Pyruvate Kinase-M2 (PKM2) in Ovarian Cancer SKOV3 and OVCAR3 Cells
【24h】

Inhibition of Proliferation, Migration, and Invasion by Knockdown of Pyruvate Kinase-M2 (PKM2) in Ovarian Cancer SKOV3 and OVCAR3 Cells

机译:通过抑制丙酮酸激酶-M2(PKM2)在卵巢癌SKOV3和OVCAR3细胞中的增殖,迁移和侵袭抑制

获取原文
获取原文并翻译 | 示例
       

摘要

Pyruvate kinase (PK) is a key enzyme in the process of glycolysis, catalyzing phosphoenolpyruvate (PEP) into pyruvate. Currently, PK isozyme type M2 (PKM2), one subtype of PK, has been proposed as a new tumor marker with high expression in various tumor tissues. Here we aimed to explore the effects of siRNA-PKM2 on ovarian carcinoma (OC) cell lines SKOV3 and OVCAR3, in which PKM2 was notably expressed. PKM2 gene interference lentivirus vectors were built by miRNA transfection assay. siRNA-PKM2-transfected SKOV3 and OVCAR3 cells were evaluated for cell proliferation, cell cycle distribution, cell apoptosis, cell migration, and invasion in this study. In addition, the expression levels of several tumor-related genes were measured using real-time PCR and Western blot. Results showed that siRNA-PKM2 markedly inhibited cell proliferation, induced apoptosis, and caused cell cycle arrest at the G(0)/G(1) phase. Cell migration and invasion were significantly suppressed by siRNA-PKM2. Furthermore, the tumor-related genes caspase 7, Bad, and E-cadherin were upregulated, while MMP2, HIF1 alpha, VEGF, and MMP9 were depressed by siRNA-PKM2. The function of siRNA-PKM2 on the biological behavior of OC cells indicated that PKM2 may also be a target for treatment of OC.
机译:丙酮酸激酶(PK)是糖酵解过程中的关键酶,可将磷酸烯醇丙酮酸(PEP)催化为丙酮酸。目前,已经提出PK同工酶M2型(PKM2)是PK的一种亚型,它是在各种肿瘤组织中高表达的新型肿瘤标志物。在这里,我们旨在探讨siRNA-PKM2对卵巢癌(OC)细胞系SKOV3和OVCAR3的影响,其中PKM2明显表达。通过miRNA转染法构建了PKM2基因干扰慢病毒载体。在这项研究中,评估了转染siRNA-PKM2的SKOV3和OVCAR3细胞的细胞增殖,细胞周期分布,细胞凋亡,细胞迁移和侵袭。另外,使用实时PCR和蛋白质印迹法测量了几种肿瘤相关基因的表达水平。结果表明,siRNA-PKM2明显抑制细胞增殖,诱导细胞凋亡,并导致细胞周期停滞在G(0)/ G(1)期。 siRNA-PKM2显着抑制细胞迁移和侵袭。此外,siRNA-PKM2抑制了肿瘤相关基因caspase 7,Bad和E-cadherin的表达,而MMP2,HIF1 alpha,VEGF和MMP9则被抑制。 siRNA-PKM2对OC细胞生物学行为的功能表明PKM2也可能是OC治疗的靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号